Evidence map›Paper›PMID 27227291›Full record

ReviewMicrobiology spectrum2016

Mechanisms of Antibiotic Resistance.

Jose M Munita, Cesar A Arias

Registry-linked trialAbstract readReview
In one paragraph

Review in Microbiology spectrum, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07261969 (CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in Kyrgyzstan), which is not on this map. Cited by 1,098 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,098citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07261969 narecruitingnot on this mapstarted 2024, after this paper: background citation

CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in Kyrgyzstan

TypeinterventionalSponsorRigshospitalet, DenmarkRan2024 to 2027Enrolled1,050ConditionsRespiratory Tract Infection Bacterial, Respiratory Tract Infection Viral, AMR, CRPArmsThe C-reactive protein point-of-care test (CRP-POCT), Patient information leaflets
3 · Its place in the literature

Who cites it

1,098 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Prevalence and antimicrobial resistance ofOpen veterinary journal · 2025
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. A functionally selectedApplied and environmental microbiology · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Universal-BacMicrobiologyOpen · 2026
    Article
  20. Review

1,038 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jose M MunitaDepartment of Internal Medicine, Division of Infectious Diseases, University of Texas Medical School at Houston, Houston, TX 77030.
Cesar A AriasDepartment of Internal Medicine, Division of Infectious Diseases, University of Texas Medical School at Houston, Houston, TX 77030.

Funding

Molecular Mechanisms Of Daptomycin Resistance In EnterococciR01AI093749 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2011 to 2015
$1.9M
NIAID NIH HHS R01 AI093749
6 · The paper itself

Abstract

Emergence of resistance among the most important bacterial pathogens is recognized as a major public health threat affecting humans worldwide. Multidrug-resistant organisms have not only emerged in the hospital environment but are now often identified in community settings, suggesting that reservoirs of antibiotic-resistant bacteria are present outside the hospital. The bacterial response to the antibiotic "attack" is the prime example of bacterial adaptation and the pinnacle of evolution. "Survival of the fittest" is a consequence of an immense genetic plasticity of bacterial pathogens that trigger specific responses that result in mutational adaptations, acquisition of genetic material, or alteration of gene expression producing resistance to virtually all antibiotics currently available in clinical practice. Therefore, understanding the biochemical and genetic basis of resistance is of paramount importance to design strategies to curtail the emergence and spread of resistance and to devise innovative therapeutic approaches against multidrug-resistant organisms. In this chapter, we will describe in detail the major mechanisms of antibiotic resistance encountered in clinical practice, providing specific examples in relevant bacterial pathogens.

Indexed as

Adaptation, PhysiologicalAnti-Bacterial AgentsBacteriaBacterial InfectionsDrug Resistance, MicrobialDrug Resistance, Multiple, BacterialHumansMutationAnti-Bacterial Agents

Identifiers

PMID27227291
PMCPMC4888801

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.